Exuma Biotech

EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015, the company is focused on creating safe, scalable, and accessible therapies that eliminate traditional barriers to CAR-T treatment. Headquartered in West Palm Beach, Florida with operations across the Cayman Islands and Asia, EXUMA takes a globally integrated approach to science and development. Our mission is to create safe, effective, and accessible therapies through platforms designed for high-throughput discovery, tumor-specific targeting, and point-of-care delivery.